Search Results - "Paul, Sanjoy K"

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes by Holman, Rury R, Paul, Sanjoy K, Bethel, M. Angelyn, Matthews, David R, Neil, H. Andrew W

“…This trial was conducted to determine whether the reduction in microvascular risk and improved glycemic control that had been observed with medical therapy, as…”
Get full text

Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes by Holman, Rury R, Paul, Sanjoy K, Bethel, M. Angelyn, Neil, H. Andrew W, Matthews, David R

“…A post-trial monitoring study involving follow-up of patients with type 2 diabetes who had been assigned to tight or less-tight blood-pressure control revealed…”
Get full text

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes by Holman, Rury R, Farmer, Andrew J, Davies, Melanie J, Levy, Jonathan C, Darbyshire, Julie L, Keenan, Joanne F, Paul, Sanjoy K

“…In this 3-year multicenter trial, patients with suboptimal glycated hemoglobin levels while receiving metformin and sulfonylurea therapy were randomly assigned…”
Get full text

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis by Kennedy, Glen A., Tey, Siok-Keen, Buizen, Luke, Varelias, Antiopi, Gartlan, Kate H., Curley, Cameron, Olver, Stuart D., Chang, Karshing, Butler, Jason P., Misra, Ashish, Subramoniapillai, Elango, Morton, A. James, Durrant, Simon, Henden, Andrea S., Moore, John, Ritchie, David, Gottlieb, David, Cooney, Julian, Paul, Sanjoy K., Hill, Geoffrey R.

“…We determined the efficacy of tocilizumab (TCZ) in preventing grade 2-4 acute graft-versus-host disease (aGVHD) in patients with acute leukemia or…”
Get full text

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease by Green, Jennifer B., MD, Bethel, M. Angelyn, MD, Paul, Sanjoy K., PhD, Ring, Arne, PhD, Kaufman, Keith D., MD, Shapiro, Deborah R., DrPH, Califf, Robert M., MD, Holman, Rury R., MB, ChB, FRCP

“…Sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, lowers blood glucose when administered as monotherapy or in combination with other antihyperglycemic…”
Get full text

Promoting Activity in Geriatric Rehabilitation: A Randomized Controlled Trial of Accelerometry by Peel, Nancye M, Paul, Sanjoy K, Cameron, Ian D, Crotty, Maria, Kurrle, Susan E, Gray, Leonard C

“…Low activity levels in inpatient rehabilitation are associated with adverse outcomes. The study aimed to test whether activity levels can be increased by the…”
Get full text

Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis by Owusu Adjah, Ebenezer S, Bellary, Srikanth, Hanif, Wasim, Patel, Kiran, Khunti, Kamlesh, Paul, Sanjoy K

“…To estimate the risk of developing long-term major cardiovascular and renal complications in relation to levels of body mass index (BMI) in a population of…”
Get full text

The association between body mass index and mortality in incident dialysis patients by Badve, Sunil V, Paul, Sanjoy K, Klein, Kerenaftali, Clayton, Philip A, Hawley, Carmel M, Brown, Fiona G, Boudville, Neil, Polkinghorne, Kevan R, McDonald, Stephen P, Johnson, David W

“…To study the body mass index (BMI) trajectory in patients with incident end-stage kidney disease and its association with all-cause mortality. This…”
Get full text

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis by Paul, Sanjoy K, Montvida, Olga, Best, Jennie H, Gale, Sara, Pethö-Schramm, Attila, Sarsour, Khaled

“…ObjectiveTo explore possible associations of treatment with biological disease-modifying antirheumatic drugs (bDMARDs), including T-cell-based and…”
Get full text

A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes by Luo, Yingying, Wang, Hongyuan, Zhou, Xianghai, Chang, Cuiqing, Chen, Wei, Guo, Xiaohui, Yang, Jinkui, Ji, Linong, Paul, Sanjoy K.

“…Aims. Prediabetes has been proved as an important risk factor of both diabetes and cardiovascular disease (CVD). Previous studies have shown that both…”
Get full text

Orthosis-Shaped Sandals Are as Efficacious as In-Shoe Orthoses and Better than Flat Sandals for Plantar Heel Pain: A Randomized Control Trial by Vicenzino, Bill, McPoil, Thomas G, Stephenson, Aoife, Paul, Sanjoy K

“…To investigate efficacy of a contoured sandal being marketed for plantar heel pain with comparison to a flat flip-flop and contoured in-shoe insert/orthosis…”
Get full text

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes by Montvida, Olga, Shaw, Jonathan, Atherton, John J, Stringer, Frances, Paul, Sanjoy K

“…To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patterns, along with glycemic levels and comorbidities, and possible…”
Get full text

A screen-based simulation training program to improve palliative care of people with advanced dementia living in residential aged care facilities and reduce hospital transfers: study protocol for the IMproving Palliative care Education and Training Using Simulation in Dementia (IMPETUS-D) cluster randomised controlled trial by Tropea, Joanne, Johnson, Christina E, Nestel, Debra, Paul, Sanjoy K, Brand, Caroline A, Hutchinson, Anastasia F, Bicknell, Ross, Lim, Wen Kwang

“…Many people with advanced dementia live in residential aged care homes. Care home staff need the knowledge and skills to provide high-quality end-of-life (EOL)…”
Get full text

The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study by Paul, Sanjoy K, Bhatt, Deepak L, Montvida, Olga

“…The aim of this study was to evaluate the temporal pattern of amputations in patients with type 2 diabetes mellitus (T2DM), the risk of amputations by new and…”
Get full text

Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study by Khunti, Kamlesh, Davies, Melanie, Majeed, Azeem, Thorsted, Brian Larsen, Wolden, Michael Lyng, Paul, Sanjoy K

“…Hypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally…”
Get full text

Racial disparity in the co-occurrence of depression and type 2 diabetes mellitus. An electronic medical record study involving African American and White Caucasian adults from the US by Dibato, John, Montvida, Olga, Sanjoy, Paul K.

“…Depression and diabetes commonly co-exist, however the temporal trends in the bidirectional association of both diseases in different sociodemographic setting…”
Get full text

The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients by Zhang, Xiuying, Sun, Haidan, Paul, Sanjoy K, Wang, Quanhui, Lou, Xiaomin, Hou, Guixue, Wen, Bo, Ji, Linong, Liu, Siqi

“…The Xiaoke Pill containing Chinese herb extracts and Glibenclamide, is used in therapy for type 2 diabetes mellitus (T2DM), and is effective in reducing the…”
Get full text

1030-P: Cardiorenal Complications in Young-Onset T2DM Compared between White Caucasian and African American in the USA by PAUL, SANJOY K., MONTVIDA, OLGA

“…Aim: Complex associations between T2DM, CKD and HF challenge treatment strategies and results in significant life years loss. Risk of CKD and HF in young- and…”
Get full text

Cardiovascular Risk Factor Burden in People With Incident Type 2 Diabetes in the U.S. Receiving Antidiabetic and Cardioprotective Therapies by Montvida, Olga, Cai, Xiaoling, Paul, Sanjoy K

“…Individualized treatment of patients with diabetes requires detailed evaluation of risk factor dynamics at the population level. This study evaluated the…”
Get full text

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients? by Roberts, Jason A., Paul, Sanjoy K., Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Dimopoulos, George, Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C., Lipman, Jeffrey

“…Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether β-lactam…”
Get full text